Publicacións en colaboración con investigadores/as de Helmholtz Zentrum München (14)

2023

  1. Gut hormone co-agonists for the treatment of obesity: from bench to bedside

    Nature Metabolism, Vol. 5, Núm. 6, pp. 933-944

  2. Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy

    Diabetologia, Vol. 66, Núm. 10, pp. 1796-1808

2022

  1. An updated view on human neonatal thermogenesis

    Nature Reviews Endocrinology

  2. Gene therapy targeting the blood-brain barrier improves neurological symptoms in a model of genetic MCT8 deficiency

    Brain : a journal of neurology, Vol. 145, Núm. 12, pp. 4264-4274

2021

  1. Is LRP2 involved in leptin transport over the blood-brain barrier and development of obesity?

    International Journal of Molecular Sciences, Vol. 22, Núm. 9

  2. O-GlcNAcylated p53 in the liver modulates hepatic glucose production

    Nature Communications, Vol. 12, Núm. 1

  3. Small extracellular vesicle-mediated targeting of hypothalamic AMPKα1 corrects obesity through BAT activation

    Nature Metabolism, Vol. 3, Núm. 10, pp. 1415-1431

2020

  1. Type 2 diabetes risk gene Dusp8 regulates hypothalamic Jnk signaling and insulin sensitivity

    Journal of Clinical Investigation, Vol. 130, Núm. 11, pp. 6093-6108

2019

  1. Functional identity of hypothalamic melanocortin neurons depends on Tbx3

    Nature Metabolism, Vol. 1, Núm. 2, pp. 222-235

2018

  1. Ghrelin and LEAP-2: Rivals in Energy Metabolism

    Trends in Pharmacological Sciences, Vol. 39, Núm. 8, pp. 685-694

  2. p53 in AgRP neurons is required for protection against diet-induced obesity via JNK1

    Nature Communications, Vol. 9, Núm. 1

2017

  1. Current Understanding of the Hypothalamic Ghrelin Pathways Inducing Appetite and Adiposity

    Trends in Neurosciences, Vol. 40, Núm. 3, pp. 167-180

2015

  1. Ghrelin

    Molecular Metabolism, Vol. 4, Núm. 6, pp. 437-460

2013

  1. Ghrelin

    Handbook of Biologically Active Peptides (Elsevier Inc.), pp. 1104-1110